Chemours Co CC.N, CC is expected to show a rise in quarterly revenue when it reports results on August 5 for the period ending June 30 2025
The Wilmington Delaware-based company is expected to report a 1.8% increase in revenue to $1.565 billion from $1.54 billion a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on June 18 2025, for the period ended June 30, was for revenue between $1.56 billion and $1.59 billion.
LSEG's mean analyst estimate for Chemours Co is for earnings of 46 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Chemours Co is $15.00, about 23.3% above its last closing price of $11.50
The company's guidance on May 6 2025 for the period ended June 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between USD1.55952 billion and USD298.7 million.The company's guidance on May 6 2025 for the period ended June 30 was for Capital Expenditures of USD50 million.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.18
0.21
0.13
Missed
-38.9
Dec. 31 2025
0.12
0.12
0.11
Missed
-5.4
Sep. 30 2024
0.29
0.28
0.40
Beat
40.9
Jun. 30 2024
0.49
0.57
0.38
Missed
-33.6
Mar. 31 2024
0.19
0.18
0.32
Beat
75
Dec. 31 2023
0.26
0.25
0.31
Beat
22.2
Sep. 30 2023
0.70
0.69
0.63
Missed
-8.8
Jun. 30 2023
1.07
1.07
1.10
Beat
2.4
This summary was machine generated August 1 at 21:10 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)